The content on this site is intended for healthcare professionals only
The Institute of Cancer Research, Sutton, UK
Princess Margaret Hospital and University of Toronto, Canada
Princess Margaret Hospital and University of Toronto, Canada
Princess Margaret Hospital and University of Toronto, Canada
Results of the new Cetuximab studies in mCRC, from ASCO 2008
Cetuximab for NSCLC, from ASCO 2008
Cetuximab for NSCLC, from ASCO 2008
Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008
Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008
Highlights and headlines anticipated at the joint ECCO 15 - 34th ESMO Multidisciplinary Congress
EBCC 6: Conference highlights from Europa Donna
